LILRB1 and neoplasm: In contrast, characterization of the humanized IgG4 anti-LILRB1 antibody BND-22 revealed that this antibody was effective also as single agent in inducing phagocytosis of tumor cells by human macrophages both in vitro and in a xenograft in vivo model in which both human macrophages and cancer cells were transferred (113).